170 related articles for article (PubMed ID: 20564276)
1. Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.
Cubo L; Groessl M; Dyson PJ; Quiroga AG; Navarro-Ranninger C; Casini A
ChemMedChem; 2010 Aug; 5(8):1335-43. PubMed ID: 20564276
[TBL] [Abstract][Full Text] [Related]
2. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
Benedetti BT; Quintal S; Farrell NP
Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
[TBL] [Abstract][Full Text] [Related]
3. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
4. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
Cubo L; Hambley TW; Sanz Miguel PJ; Carnero A; Navarro-Ranninger C; Quiroga AG
Dalton Trans; 2011 Jan; 40(2):344-7. PubMed ID: 20936210
[TBL] [Abstract][Full Text] [Related]
5. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
6. Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.
Samper KG; Vicente C; Rodríguez V; Atrian S; Cutillas N; Capdevila M; Ruiz J; Palacios Ò
Dalton Trans; 2012 Jan; 41(1):300-6. PubMed ID: 22089173
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Pt-protein complexes by nHPLC-ESI-LTQ MS/MS using a gel-based bottom-up approach.
Moreno-Gordaliza E; Cañas B; Palacios MA; Gómez-Gómez MM
Talanta; 2012 Jan; 88():599-608. PubMed ID: 22265547
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems.
Mügge C; Musumeci D; Michelucci E; Porru F; Marzo T; Massai L; Messori L; Weigand W; Montesarchio D
J Inorg Biochem; 2016 Jul; 160():198-209. PubMed ID: 26921982
[TBL] [Abstract][Full Text] [Related]
9. The second generation of iodido complexes: trans-[PtI2(amine)(amine')] bearing different aliphatic amines.
Parro T; Medrano MA; Cubo L; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
J Inorg Biochem; 2013 Oct; 127():182-7. PubMed ID: 23688840
[TBL] [Abstract][Full Text] [Related]
10. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.
Küng A; Strickmann DB; Galanski MS; Keppler BK
J Inorg Biochem; 2001 Oct; 86(4):691-8. PubMed ID: 11583787
[TBL] [Abstract][Full Text] [Related]
12. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
[TBL] [Abstract][Full Text] [Related]
13. ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins.
Marzo T; De Pascali SA; Gabbiani C; Fanizzi FP; Messori L; Pratesi A
Biometals; 2017 Aug; 30(4):609-614. PubMed ID: 28677079
[TBL] [Abstract][Full Text] [Related]
14. Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.
Li H; Lin TY; Van Orden SL; Zhao Y; Barrow MP; Pizarro AM; Qi Y; Sadler PJ; O'Connor PB
Anal Chem; 2011 Dec; 83(24):9507-15. PubMed ID: 22032417
[TBL] [Abstract][Full Text] [Related]
15. Guanine nucleobase adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: evidence that a tridentate ligand with only in-plane bulk can slow guanine base rotation.
Andrepont C; Marzilli PA; Marzilli LG
Inorg Chem; 2012 Nov; 51(21):11961-70. PubMed ID: 23094695
[TBL] [Abstract][Full Text] [Related]
16. Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.
Farrer NJ; Woods JA; Munk VP; Mackay FS; Sadler PJ
Chem Res Toxicol; 2010 Feb; 23(2):413-21. PubMed ID: 19994893
[TBL] [Abstract][Full Text] [Related]
17. Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.
Kasherman Y; Sturup S; Gibson D
J Biol Inorg Chem; 2009 Mar; 14(3):387-99. PubMed ID: 19052781
[TBL] [Abstract][Full Text] [Related]
18. Monofunctional platinum amine complexes destabilize DNA significantly.
Bauer C; Peleg-Shulman T; Gibson D; Wang AH
Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
[TBL] [Abstract][Full Text] [Related]
19. Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins.
Najajreh Y; Peleg-Shulman T; Moshel O; Farrell N; Gibson D
J Biol Inorg Chem; 2003 Jan; 8(1-2):167-75. PubMed ID: 12459912
[TBL] [Abstract][Full Text] [Related]
20. Mixed natural arylolefin-quinoline platinum(II) complexes: synthesis, structural characterization and in vitro cytotoxicity studies.
Chi NTT; Thong PV; Mai TTC; Van Meervelt L
Acta Crystallogr C Struct Chem; 2018 Dec; 74(Pt 12):1732-1743. PubMed ID: 30516159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
